Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers

BACKGROUND A patient-derived organoid (PDO) platform may serve as a promising tool for translational cancer research. In this study, we evaluated PDO’s ability to predict clinical response to gastrointestinal (GI) cancers.METHODS We generated PDOs from primary and metastatic lesions of patients with...

Full description

Bibliographic Details
Main Authors: Tara L. Hogenson, Hao Xie, William J. Phillips, Merih D. Toruner, Jenny J. Li, Isaac P. Horn, Devin J. Kennedy, Luciana L. Almada, David L. Marks, Ryan M. Carr, Murat Toruner, Ashley N. Sigafoos, Amanda N. Koenig-Kappes, Rachel L.O. Olson, Ezequiel J. Tolosa, Cheng Zhang, Hu Li, Jason D. Doles, Jonathan Bleeker, Michael T. Barrett, James H. Boyum, Benjamin R. Kipp, Amit Mahipal, Joleen M. Hubbard, Temperance J. Scheffler Hanson, Gloria M. Petersen, Surendra Dasari, Ann L. Oberg, Mark J. Truty, Rondell P. Graham, Michael J. Levy, Mojun Zhu, Daniel D. Billadeau, Alex A. Adjei, Nelson Dusetti, Juan L. Iovanna, Tanios S. Bekaii-Saab, Wen Wee Ma, Martin E. Fernandez-Zapico
Format: Article
Language:English
Published: American Society for Clinical investigation 2022-11-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.158060
_version_ 1827768083088932864
author Tara L. Hogenson
Hao Xie
William J. Phillips
Merih D. Toruner
Jenny J. Li
Isaac P. Horn
Devin J. Kennedy
Luciana L. Almada
David L. Marks
Ryan M. Carr
Murat Toruner
Ashley N. Sigafoos
Amanda N. Koenig-Kappes
Rachel L.O. Olson
Ezequiel J. Tolosa
Cheng Zhang
Hu Li
Jason D. Doles
Jonathan Bleeker
Michael T. Barrett
James H. Boyum
Benjamin R. Kipp
Amit Mahipal
Joleen M. Hubbard
Temperance J. Scheffler Hanson
Gloria M. Petersen
Surendra Dasari
Ann L. Oberg
Mark J. Truty
Rondell P. Graham
Michael J. Levy
Mojun Zhu
Daniel D. Billadeau
Alex A. Adjei
Nelson Dusetti
Juan L. Iovanna
Tanios S. Bekaii-Saab
Wen Wee Ma
Martin E. Fernandez-Zapico
author_facet Tara L. Hogenson
Hao Xie
William J. Phillips
Merih D. Toruner
Jenny J. Li
Isaac P. Horn
Devin J. Kennedy
Luciana L. Almada
David L. Marks
Ryan M. Carr
Murat Toruner
Ashley N. Sigafoos
Amanda N. Koenig-Kappes
Rachel L.O. Olson
Ezequiel J. Tolosa
Cheng Zhang
Hu Li
Jason D. Doles
Jonathan Bleeker
Michael T. Barrett
James H. Boyum
Benjamin R. Kipp
Amit Mahipal
Joleen M. Hubbard
Temperance J. Scheffler Hanson
Gloria M. Petersen
Surendra Dasari
Ann L. Oberg
Mark J. Truty
Rondell P. Graham
Michael J. Levy
Mojun Zhu
Daniel D. Billadeau
Alex A. Adjei
Nelson Dusetti
Juan L. Iovanna
Tanios S. Bekaii-Saab
Wen Wee Ma
Martin E. Fernandez-Zapico
author_sort Tara L. Hogenson
collection DOAJ
description BACKGROUND A patient-derived organoid (PDO) platform may serve as a promising tool for translational cancer research. In this study, we evaluated PDO’s ability to predict clinical response to gastrointestinal (GI) cancers.METHODS We generated PDOs from primary and metastatic lesions of patients with GI cancers, including pancreatic ductal adenocarcinoma, colorectal adenocarcinoma, and cholangiocarcinoma. We compared PDO response with the observed clinical response for donor patients to the same treatments.RESULTS We report an approximately 80% concordance rate between PDO and donor tumor response. Importantly, we found a profound influence of culture media on PDO phenotype, where we showed a significant difference in response to standard-of-care chemotherapies, distinct morphologies, and transcriptomes between media within the same PDO cultures.CONCLUSION While we demonstrate a high concordance rate between donor tumor and PDO, these studies also showed the important role of culture media when using PDOs to inform treatment selection and predict response across a spectrum of GI cancers.TRIAL REGISTRATION Not applicable.FUNDING The Joan F. & Richard A. Abdoo Family Fund in Colorectal Cancer Research, GI Cancer program of the Mayo Clinic Cancer Center, Mayo Clinic SPORE in Pancreatic Cancer, Center of Individualized Medicine (Mayo Clinic), Department of Laboratory Medicine and Pathology (Mayo Clinic), Incyte Pharmaceuticals and Mayo Clinic Hepatobiliary SPORE, University of Minnesota-Mayo Clinic Partnership, and the Early Therapeutic program (Department of Oncology, Mayo Clinic).
first_indexed 2024-03-11T12:07:13Z
format Article
id doaj.art-f973dfbdbe53458f81a1c8da0742e768
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-03-11T12:07:13Z
publishDate 2022-11-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-f973dfbdbe53458f81a1c8da0742e7682023-11-07T16:24:51ZengAmerican Society for Clinical investigationJCI Insight2379-37082022-11-01722Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancersTara L. HogensonHao XieWilliam J. PhillipsMerih D. TorunerJenny J. LiIsaac P. HornDevin J. KennedyLuciana L. AlmadaDavid L. MarksRyan M. CarrMurat TorunerAshley N. SigafoosAmanda N. Koenig-KappesRachel L.O. OlsonEzequiel J. TolosaCheng ZhangHu LiJason D. DolesJonathan BleekerMichael T. BarrettJames H. BoyumBenjamin R. KippAmit MahipalJoleen M. HubbardTemperance J. Scheffler HansonGloria M. PetersenSurendra DasariAnn L. ObergMark J. TrutyRondell P. GrahamMichael J. LevyMojun ZhuDaniel D. BilladeauAlex A. AdjeiNelson DusettiJuan L. IovannaTanios S. Bekaii-SaabWen Wee MaMartin E. Fernandez-ZapicoBACKGROUND A patient-derived organoid (PDO) platform may serve as a promising tool for translational cancer research. In this study, we evaluated PDO’s ability to predict clinical response to gastrointestinal (GI) cancers.METHODS We generated PDOs from primary and metastatic lesions of patients with GI cancers, including pancreatic ductal adenocarcinoma, colorectal adenocarcinoma, and cholangiocarcinoma. We compared PDO response with the observed clinical response for donor patients to the same treatments.RESULTS We report an approximately 80% concordance rate between PDO and donor tumor response. Importantly, we found a profound influence of culture media on PDO phenotype, where we showed a significant difference in response to standard-of-care chemotherapies, distinct morphologies, and transcriptomes between media within the same PDO cultures.CONCLUSION While we demonstrate a high concordance rate between donor tumor and PDO, these studies also showed the important role of culture media when using PDOs to inform treatment selection and predict response across a spectrum of GI cancers.TRIAL REGISTRATION Not applicable.FUNDING The Joan F. & Richard A. Abdoo Family Fund in Colorectal Cancer Research, GI Cancer program of the Mayo Clinic Cancer Center, Mayo Clinic SPORE in Pancreatic Cancer, Center of Individualized Medicine (Mayo Clinic), Department of Laboratory Medicine and Pathology (Mayo Clinic), Incyte Pharmaceuticals and Mayo Clinic Hepatobiliary SPORE, University of Minnesota-Mayo Clinic Partnership, and the Early Therapeutic program (Department of Oncology, Mayo Clinic).https://doi.org/10.1172/jci.insight.158060OncologyTherapeutics
spellingShingle Tara L. Hogenson
Hao Xie
William J. Phillips
Merih D. Toruner
Jenny J. Li
Isaac P. Horn
Devin J. Kennedy
Luciana L. Almada
David L. Marks
Ryan M. Carr
Murat Toruner
Ashley N. Sigafoos
Amanda N. Koenig-Kappes
Rachel L.O. Olson
Ezequiel J. Tolosa
Cheng Zhang
Hu Li
Jason D. Doles
Jonathan Bleeker
Michael T. Barrett
James H. Boyum
Benjamin R. Kipp
Amit Mahipal
Joleen M. Hubbard
Temperance J. Scheffler Hanson
Gloria M. Petersen
Surendra Dasari
Ann L. Oberg
Mark J. Truty
Rondell P. Graham
Michael J. Levy
Mojun Zhu
Daniel D. Billadeau
Alex A. Adjei
Nelson Dusetti
Juan L. Iovanna
Tanios S. Bekaii-Saab
Wen Wee Ma
Martin E. Fernandez-Zapico
Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
JCI Insight
Oncology
Therapeutics
title Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
title_full Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
title_fullStr Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
title_full_unstemmed Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
title_short Culture media composition influences patient-derived organoid ability to predict therapeutic responses in gastrointestinal cancers
title_sort culture media composition influences patient derived organoid ability to predict therapeutic responses in gastrointestinal cancers
topic Oncology
Therapeutics
url https://doi.org/10.1172/jci.insight.158060
work_keys_str_mv AT taralhogenson culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT haoxie culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT williamjphillips culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT merihdtoruner culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT jennyjli culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT isaacphorn culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT devinjkennedy culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT lucianalalmada culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT davidlmarks culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT ryanmcarr culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT murattoruner culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT ashleynsigafoos culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT amandankoenigkappes culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT rachelloolson culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT ezequieljtolosa culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT chengzhang culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT huli culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT jasonddoles culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT jonathanbleeker culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT michaeltbarrett culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT jameshboyum culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT benjaminrkipp culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT amitmahipal culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT joleenmhubbard culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT temperancejschefflerhanson culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT gloriampetersen culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT surendradasari culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT annloberg culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT markjtruty culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT rondellpgraham culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT michaeljlevy culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT mojunzhu culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT danieldbilladeau culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT alexaadjei culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT nelsondusetti culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT juanliovanna culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT taniossbekaiisaab culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT wenweema culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers
AT martinefernandezzapico culturemediacompositioninfluencespatientderivedorganoidabilitytopredicttherapeuticresponsesingastrointestinalcancers